Loading...
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Shitara, K Doi, T Dvorkin, M Mansoor, Was Arkenau, H Prokharau, A Alsina, M Ghidini, M Faustino, C Gorbunova, V
Shitara, K
Doi, T
Dvorkin, M
Mansoor, Was
Arkenau, H
Prokharau, A
Alsina, M
Ghidini, M
Faustino, C
Gorbunova, V
Citations
Altmetric:
Abstract
Trifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of pretreated patients with advanced gastric cancer done in Japan. We investigated whether the treatment was efficacious compared with placebo in a global population.
Description
Date
2018
Publisher
Collections
Keywords
Type
Article
Citation
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial. 2018 Lancet Oncol